KNSA Stock Analysis: Buy, Sell, or Hold?
KNSA - Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
$73.41
-0.93 (-1.25%)
▼
5d:
+15.54%
30d:
+13.76%
90d:
+32.82%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When KNSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KNSA trades at premium valuation expecting 19.5% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: KNSA trades at premium valuation expecting 19.5% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$74.16
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$46.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: KNSA is currently trading at $73.41, which is considered extended relative to its 30-day fair value range of $58.32 to $68.93. From a valuation perspective, the stock is trading at a premium (Forward PE: 48.8) compared to its historical average (28.6). At these levels, the market is pricing in 19.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, KNSA is in a strong uptrend. Immediate support is located at $61.60, while resistance sits at $82.94.
Market Sentiment: KNSA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $98.00 (+31.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KNSA is in a strong uptrend. Immediate support is located at $61.60, while resistance sits at $82.94.
Market Sentiment: KNSA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $98.00 (+31.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$58.32 -
$68.93
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding KNSA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.5% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.8% below Wall St target ($98.00)
- NEUTRAL: Trading at premium valuation - market expects 19.5% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$58.32 -
$68.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$61.60
Resistance Level
$82.94
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
48.80
Wall Street Target
$98.00
(+31.8%)
Revenue Growth (YoY)
55.4%
Earnings Growth (YoY)
30.4%
Profit Margin
9.6%
Valuation Premium vs History
+19.5% premium
PE vs Historical
48.8 vs 28.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+19.5%
(market-implied from PE analysis)
1-Year Target
$88.84
(+20%)
2-Year Target
$106.16
(+43%)
3-Year Target
$126.86
(+71%)
3-Yr Target (if PE normalizes)
(PE: 49→29)
PE COMPRESSION
$74.35
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 48.8, Growth: 34.4%)
$180.53
(+143%)
Base:
(SPY PE: 20.7, Growth: 34.4%)
$76.68
(+3%)
Bear:
(PE: 17.6, Growth: 34.4%)
$65.18
(-12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (82x PE), but valuation improves significantly next year (49x PE) as earnings recover.
Trailing PE: 82.32 | Current EPS (TTM): $0.95
Bull Case
$137.93
(+88%)
Analyst growth 60.3%, PE expands to 90.6
Base Case
$125.39
(+71%)
Market implied 60.3%, PE stable at 82.3
Bear Case
$53.18
(-28%)
Severe decline -20.0%, PE contracts to 70.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 03, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KNSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Ross Moat
SELL
1703 shares
2026-04-09
Michael R Megna
SELL
6625 shares
2026-04-09
Barry D Quart
SELL
6901 shares
2026-04-06
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced KNSA Option Strategies
Professional options setups generated by AI based on today's KNSA price and gamma walls.
